Takeda Pharmaceutical
Dana Mendenhall is a seasoned executive with extensive experience in the pharmaceutical and medical device industries. Most recently, Dana served as Senior Vice President and Global Head of Commercial and Portfolio Strategy for Plasma Derived Therapies at Takeda Pharmaceuticals, focusing on global growth and commercialization strategies. Prior roles include Vice President of Marketing for BD, and Vice President of Marketing for the Renal Division at Baxter International Inc., where Dana led significant market transformations and commercial turnarounds. Additionally, Dana has a strong foundation in cross-functional roles at Ethicon, Inc. and holds an MBA from Northwestern University's Kellogg School of Management and a Bachelor's Degree in Industrial Engineering from Texas A&M University.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.